Every year, the Environmental Working Group tests the amounts of pesticides that remain on fruit and vegetables after they have been picked, power washed and stocked onto grocery store shelves.

Balance and walking problems often present before the diagnosis of mild cognitive impairment, Alzheimer’s or dementia… Alzheimer’s Reading Room When I first came to Delray Beach to take care of my mother, she was falling down all the time. Once, I found her laying in the parking lot and…

Why are we still turning Afghanistan into chopped liver?

Alzheimer’s Reading Room “Anti-amyloid therapeutic drugs represent a valid approach to treating Alzheimer’s disease, but their inability to accumulate in the brain has limited their usefulness,” says Greengard, who is head of the Laboratory of Molecular and Cellular Neuroscience. “The development of compounds that work like Gleevec, but have…

GlaxoSmithKline PLC (GSK) and Human Genome Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted a priority review designation to Benlysta® (belimumab) as a potential treatment for systemic lupus erythematosus (SLE).

Original Source of GlaxoSmithKline and Human Genome Sciences announce FDA priority review designation for…

Bristol-Myers Squibb Company (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients with advanced melanoma who have been previously treated.

Original Source of Ipilimumab Receives FDA Priority Review…

Eli Lilly and Company (NYSE: LLY) will halt development of semagacestat, a gamma secretase inhibitor being studied as a potential treatment for Alzheimer’s disease,

Original Source of Lilly Halts Development of Semagacestat for Alzheimer’s Disease

The U.S. Food and Drug Administration proposed to withdraw approval of the drug midodrine hydrochloride, used to treat the low blood pressure condition orthostatic hypotension, because required post-approval studies that verify the clinical benefit of the drug have not been done.

Original Source of FDA Proposes Withdrawal of Low Blood…

Many companies in the cell therapy regenerative medicine market including Roche, Genzyme, Athersys, Miltenyi Biotec, Hospira, Lonza and Life Technologies will join ISCT to launch a series of new initiatives that will create greater strategic alignment within the industry and drive late stage clinical development.

Original Source of International Society…

Pharmaceutical and healthcare market research company Manhattan Research releases the tenth version of ePharma Physician®, its study focused on physicians connecting with pharmaceutical and biotech companies through the Internet, tech-enabled reps, and online promotion.

Original Source of Data on Electronic Sampling, Online Promotion, Tech-Enabled Reps, Customer Service, and iPads